HB 572-FN - AS INTRODUCED
2017 SESSION
17-0196
01/04
HOUSE BILL 572-FN
AN ACT extending the suspension of prior authorization requirements for a community mental health program on drugs used to treat mental illness.
SPONSORS: Rep. Snow, Hills. 42; Rep. Fothergill, Coos 1; Rep. Freitas, Hills. 14; Rep. Heath, Hills. 14; Rep. J. MacKay, Merr. 14; Rep. M. MacKay, Hills. 30; Rep. LeBrun, Hills. 32; Sen. Carson, Dist 14; Sen. Feltes, Dist 15; Sen. McGilvray, Dist 16
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
This bill extends the suspension of prior authorization requirement for a community mental health program on drugs used to treat mental illness.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
17-0196
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Seventeen
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Prior Authorization for Certain Prescription Drugs; Suspension; Repeal. Amend 2015, 199:4, I as amended by 2016, 211:1 to read as follows:
I. Section 3 of this act shall take effect June 30, [2017] 2018.
2 Effective Date. This act shall take effect upon its passage.
17-0196
Revised 3/13/17
HB 572-FN- FISCAL NOTE
AS INTRODUCED
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
|
| |||
| Estimated Increase / (Decrease) | |||
STATE: | FY 2018 | FY 2019 | FY 2020 | FY 2021 |
Appropriation | $0 | $0 | $0 | $0 |
Revenue | $0 | $0 | $0 | $0 |
Expenditures | Indeterminable Increase | $0 | $0 | $0 |
Funding Source: | [ X ] General [ ] Education [ ] Highway [ ] Other | |||
METHODOLOGY:
This bill extends the suspension of prior authorization requirements that relate to the ability of community mental health programs to prescribe medication that treats severe mental illness. Currently, RSA 126-A:5, XIX(e) requires managed care organizations (MCO) providing prescription drug benefits to Medicaid recipients to suspend prior authorization requirements for medication prescribed at a community mental health center and used to treat severe mental illness such as schizophrenia, depression, or bipolar disorder. Absent legislative action, this provision will be repealed effective June 30, 2017. By extending the repeal date, this bill continues the suspension of prior authorization requirements until June 30, 2018. The contracted actuary retained by the Department of Health and Human Services projects that this extension will increase costs by $4 million in FY 2018 in the form of higher capitated rates paid to the MCOs. This cost may be reduced, however, by the fact that NH receives rebates on prescription drugs as part of the federal Medicaid Drug Rebate Program. Although the rebate amounts are indeterminable at the time of this writing, the Department anticipates that they may result in the net cost of the bill being as low as $1,000,000 in FY18. The Department notes that this $1,000,000 cost would be the best possible scenario. As this bill relates to the Medicaid program, any cost will be paid for with 50 percent state general funds and 50 percent federal funds, and so the general fund impact under this best-case scenario would be a cost of $500,000 in FY18.
AGENCIES CONTACTED:
Departments of Health and Human Services, Insurance, and Administrative Services, and New Hampshire Municipal Association and New Hampshire Association of Counties
| Date | Body | Type |
|---|---|---|
| Feb. 8, 2017 | House | Hearing |
| Feb. 28, 2017 | House | Exec Session |
| March 8, 2017 | House | Floor Vote |
| March 13, 2017 | House | Exec Session |
| March 15, 2017 | House | Exec Session |
| Nov. 8, 2017 | House | Exec Session |
| Jan. 3, 2018 | House | Floor Vote |
Jan. 3, 2018: Inexpedient to Legislate: MA VV 01/03/2018 HJ 1 P. 35
Jan. 3, 2018: Committee Report: Inexpedient to Legislate for 01/03/2018 (Vote 26-0; CC)
Nov. 8, 2017: Executive Session: 11/08/2017 10:00 AM LOB 210-211
Sept. 28, 2017: Division III Retained Bill Work Session: 09/28/2017 01:00 PM LOB 212
: Retained in Committee
March 15, 2017: ==CONTINUED== Executive Session: 03/15/2017 04:00 PM LOB 210-211
March 15, 2017: Division III Work Session: 03/15/2017 09:00 AM LOB 210-211
March 13, 2017: ==RECESSED== Executive Session: 03/13/2017 10:00 AM LOB 210-211
March 8, 2017: Referred to Finance 03/08/2017 HJ 9 P. 35
March 8, 2017: Ought to Pass: MA VV 03/08/2017 HJ 9 P. 35
March 8, 2017: Committee Report: Ought to Pass for 03/08/2017 (Vote 21-0; CC) HC 14 P. 16
Feb. 28, 2017: ==RESCHEDULED== Executive Session: 02/28/2017 09:00 AM LOB 205
March 1, 2017: ==CANCELLED== Executive Session: 03/01/2017 10:00 AM LOB 205
Feb. 8, 2017: Public Hearing: 02/08/2017 01:15 PM LOB 205
Jan. 5, 2017: Introduced 01/05/2017 and referred to Health, Human Services and Elderly Affairs HJ 3 P. 19